US Patent 11155544 Heterocycle comprising tyrosine kinase inhibitors
Patent 11155544 was granted and assigned to Principia Biopharma Inc. on October, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 26, 2019
Date of Patent
October 26, 2021
Patent Applicant
Patent Application Number
20190726
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11155544 Heterocycle comprising tyrosine kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
